SynerFuse
Minneapolis, US · Delaware corporation
SynerFuse is a Minnesota-based medical device company developing a spinal fusion procedure combined with direct nerve stimulation to treat chronic low back and leg pain. The company's patented e-TLIF procedure integrates spinal fusion with neuromodulation as a single implant solution.
Founders & leadership
DM
Dennis McFaddeninExecutive
NP
Nazmi PeymanExecutive
GM
Gregory MolnarNamed on SEC filing
JZ
Justin ZenankoChief Executive Officer, Founder
Board
SA
Susan AlpertBoard director
Reported raises · per SEC filings
Form D private placements$6.5M disclosed across 3 of 4 rounds · 2018–2023
▶$25MofferedFeb 2023 · Other Health CareRule 506(b)
▶$25MofferedFeb 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Erika PetersenDirector
- Gregory MolnarExecutive Officer, Director
- Justin ZenankoExecutive Officer, Director, Promoter
- Edward NovinskiDirector
- Dennis McFaddenExecutive Officer
- Offering amount
- $25M
- Minimum investment
- $50K
- Sales commissions
- $2.5M
- Placement agents
- KCD Financial, Inc.
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b, 4a5
▶$275KraisedJul 2021 · 3 investors · Other Health CareRule 506(b)
▶$275KraisedJul 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Erika PetersenDirector
- Dennis McFaddenExecutive Officer
- Justin ZenankoExecutive Officer, Director, Promoter
- Nazmi PeymanDirector
- Brian HighleyDirector
- Jeff FritzDirector
- Susan AlpertExecutive Officer
- Gregory MolnarExecutive Officer, Director, Promoter
- Offering amount
- $30M
- Amount sold
- $275K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04, 06b, 4a5
▶$3.6MraisedApr 2021 · 54 investors · Other Health Care
▶$3.6MraisedApr 2021 · 54 investors · Other Health Care
Officers, directors & promoters on the filing
- Dennis McFaddenExecutive Officer
- Nazmi PeymanExecutive Officer
- Susan AlpertExecutive Officer
- Gregory MolnarExecutive Officer
- Justin ZenankoExecutive Officer, Director, Promoter
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04, 04.2, 4a5
▶$2.6MraisedMay 2019 · 54 investors · Other Health CareRule 506(b)
▶$2.6MraisedMay 2019 · 54 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Theresa Pesch HilgersDirector
- Justin D. ZenankoExecutive Officer, Director, Promoter
- Diane ThibodeauDirector
- Nazmi PeymanExecutive Officer, Director, Promoter
- Gregory MolnarExecutive Officer, Director
- Jeff O'DellDirector
- Susan AlpertExecutive Officer
- Omid SouresrafilPromoter
- Timothy SkajaDirector
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- Minimum investment
- $5K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 04, 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Fuse4 shared keywordsFuse uses AI and automation to provide price transparency in US healthcare by determining accurate insurance benefits, detecting underpayments, and delivering cost estimates to patients before treatment. The company serves healthcare providers and patients seeking clarity on medical costs and payment accuracy.
Fuse Medical4 shared keywordsFuse Medical develops orthopedic medical devices for spine, joint, and sports medicine applications. The company offers products across cervical plating, interbodies, trauma, and biologics for the orthopedic marketplace.
Practo4 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
BirdEye3 shared keywordsBirdeye offers an AI-powered platform with multi-agent "AI Coworkers" that handle marketing, operations, and customer experience tasks such as search optimization, review generation, listings management, social posting, and front-desk coordination. It serves multi-location businesses, providing a unified view of customers, locations, and interactions.
Doximity3 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with SynerFuse for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does SynerFuse do?
- SynerFuse is a Minnesota-based medical device company developing a spinal fusion procedure combined with direct nerve stimulation to treat chronic low back and leg pain. The company's patented e-TLIF procedure integrates spinal fusion with neuromodulation as a single implant solution.
- How much funding has SynerFuse raised?
- SynerFuse has disclosed $6.5M raised across 3 of its 4 known rounds.
- Where is SynerFuse headquartered?
- SynerFuse is headquartered in Minneapolis, US.